WINT - nov 26 :
WINT - nov 26 :
Wind-tree Is Studying Istaroxime in Early Cardiogenic Shock Patients
WARRINGTON, Pa., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmon
0%
0%
0%
0%
0%